J&J Diabetes Drug Effective But Carries Risks, FDA Says
The U.S. Food and Drug Administration raised concerns about safety risks in a new diabetes drug Johnson & Johnson is seeking approval for, directing an advisory committee this week to pay...To view the full article, register now.
Already a subscriber? Click here to view full article